Skip to content
Artenimol
Eurartesim (artenimol) is a small molecule pharmaceutical. Artenimol was first approved as Eurartesim on 2011-10-27. It has been approved in Europe to treat malaria.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
P: Antiparasitic products, insecticides and repellents
P01: Antiprotozoals
P01B: Antimalarials
P01BE: Artemisinin and derivatives, plain
P01BE05: Artenimol
P01BF: Artemisinin and derivatives, combinations
P01BF05: Artenimol and piperaquine
HCPCS
No data
Clinical
Clinical Trials
109 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
MalariaD008288EFO_0001068B5483319764
Falciparum malariaD016778EFO_0007444B5056125833
Vivax malariaD016780EFO_0007445B512241210
AnemiaD000740EFO_0004272D64.9325
Healthy volunteers/patients22
Hiv infectionsD015658EFO_0000764B20112
Drug interactionsD00434711
Glucosephosphate dehydrogenase deficiencyD005955EFO_000728711
Polycystic ovary syndromeD011085EFO_0000660E28.211
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
PregnancyD011247EFO_0002950Z33.122
Pregnancy rateD01887322
FeverD005334HP_0001945R50.911
Asymptomatic diseasesD05807011
Bacterial vaginosisD016585EFO_000393211
Trichomonas vaginitisD014247EFO_000752111
HivD006678O98.711
Filarial elephantiasisD004605EFO_0007272B74.011
ScabiesD012532B8611
StrongyloidiasisD013322EFO_0007501B7811
Show 2 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
CardiotoxicityD066126EFO_100148211
ParasitemiaD01851211
Systemic lupus erythematosusD008180EFO_0002690M3211
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Drug resistanceD004351Z16.3011
Angle class ii malocclusionD008312M26.21211
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameARTENIMOL
INNartenimol
Description
Dihydroartemisinin is a sesquiterpenoid compound which is used as a drug for treatment of malaria. It has a role as an antimalarial.
Classification
Small molecule
Drug classantimalarials (artemisin derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
C[C@@H]1CC[C@H]2[C@@H](C)[C@@H](O)O[C@@H]3O[C@]4(C)CC[C@@H]1[C@@]23OO4
Identifiers
PDB
CAS-ID71939-50-9
RxCUI
ChEMBL IDCHEMBL252518
ChEBI ID
PubChem CID6918483
DrugBankDB11638
UNII ID6A9O50735X (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 884 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
72,770 adverse events reported
View more details